Loading
Latest filing published 31 Jul 2019 for Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.).
No signal scores available.
All filings by Sean A. MacDonald on record concern Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.). Between 7 June 2019 and 26 July 2019, the trades on record add up to 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 31 July 2019, reports a transaction in Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.). Typically, a trade is published a median of 20 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations